Factory Centalla Asiatica Extract Madecassic Acid CAS 18449-41-7 Madecassic Acid

• Customization: Available
• Certification: RoHS, BRC, ISO, FDA, HACCP
• Assay Method: HPLC-MS, GPC, HPLC, UV
• Model NO.: C19
• Application Form: Injection, Lotion, Suppository, Paste, Tablet, Capsule
• Application: Health Care Products, Medicine
• State: Powder
• Extract Source: Centalla Asiatica Extract
• Name: Madecassic Acid
• Appearance: White Powder
• Assay: 99%
• CAS: 18449-41-7
• OEM: Available
• Sample: Available
• Suitable: Adult
• MOQ: 100g
• Function: Anti-Inflammatory
• Transport Package: Foil Bag
• Specification: 99
• Trademark: /
• Origin: China
• Production Capacity: 10000 Kgs Per Month

Product Description

Product Name	Madecassic Acid
Appearance	White Powder
CAS NO.	18449-41-7
Molecular Formula	C30H48O6
Storage	Keep in a cool, dry, dark location

 

Madecassic Acid is a triterpenoid compound isolated from the Centella asiatica plant (family Apiaceae). It is a naturally occurring substance with various biological activities.

 

1. Scientific Research: Madecassic Acid is primarily used in scientific research for studying its biological effects and potential therapeutic applications.
2. Pharmaceutical Development: Due to its anti-inflammatory and immunomodulatory properties, Madecassic Acid is being investigated for potential use in the development of new pharmaceuticals.
3. Cosmetic Industry: Its skin-beneficial properties make it a candidate for use in cosmetic products, although further research is needed to confirm its efficacy and safety in this context.

1. Anti-inflammatory Activity: Madecassic Acid exhibits inhibitory effects on iNOS, COX-2, TNF-α, IL-1beta, and IL-6, suggesting its potential as an anti-inflammatory agent.
2. Immunomodulation: It downregulates NF-κB activation in RAW 264.7 macrophages, indicating its ability to modulate immune responses.
3. Metabolic Effects: Preliminary studies suggest that Madecassic Acid may have beneficial effects on plasma fibrinogen, triglyceride levels, and reactive oxygen species (ROS) levels in the heart and kidneys, although more research is required to confirm these findings.